Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
PaperCitations, authors & open-access status
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,828 citations, 2018 year and bronze oa status.
2,828
Citations
2018
Year
bronze
OA Status